English | 繁體

Search in the results

UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
Aurora A kinase inhibition compromises its antitumor efficacy by elevating PD-L1 expression Journal article
Wang, Xiaobo, Huang, Jing, Liu, Fenglin, Yu, Qian, Wang, Ruina, Wang, Jiaqi, Zhu, Zewen, Yu, Juan, Hou, Jun, Shim, Joong Sup, Jiang, Wei, Li, Zengxia, Zhang, Yuanyuan, Dang, Yongjun. Aurora A kinase inhibition compromises its antitumor efficacy by elevating PD-L1 expression[J]. Journal of Clinical Investigation, 2023, 133(9), e161929.
Authors:  Wang, Xiaobo;  Huang, Jing;  Liu, Fenglin;  Yu, Qian;  Wang, Ruina; et al.
Favorite | TC[WOS]:16 TC[Scopus]:19  IF:13.3/14.6 | Submit date：2023/06/05
Pharmacokinetic evidence on the contribution of intestinal bacterial conversion to beneficial effects of Astragaloside IV, a marker compound of Astragali Radix, in traditional oral use of the herb Journal article
Ruina Zhou, Yuelin Song, Jianqing Ruan, Yitao Wang, Ru Yan. Pharmacokinetic evidence on the contribution of intestinal bacterial conversion to beneficial effects of Astragaloside IV, a marker compound of Astragali Radix, in traditional oral use of the herb[J]. Drug Metabolism and Pharmacokinetics, 2012, 27(6), 586-597.
Authors:  Ruina Zhou;  Yuelin Song;  Jianqing Ruan;  Yitao Wang;  Ru Yan
Favorite | TC[WOS]:60 TC[Scopus]:62 | Submit date：2018/10/30
Gut Microbial Metabolism  Oral Pharmacokinetics  Astragaloside Iv  Cycloastragenol  3-epi-cycloastragenol  Astragali Radix  Chinese Medicines  Gut Microbiota  Deglycosylation